Official EU label nameGlossary entry 10962

GINSENOSIDE RG4

This record confirms an official common ingredient name for EU cosmetic product labelling. It does not by itself confirm that the substance is permitted, unrestricted or safe.

Global evidence snapshot

The resolved identity has matching regulatory evidence in 0 of 13 indexed market datasets: 0 country records and 0 EU Annex records. Every result and evidence gap is listed below.

0 markets with evidence

Markets checked

Markets with evidence

Evidence gaps

Resolved identifiers

Resolved substance identity

CAS:126223-28-7

Ingredient index records:

GINSENOSIDE RG4

Cosmetic functions: ANTIOXIDANT

Ginsenoside F4,Ginsenoside Rg2,\b.-D-Glucopyranoside, (3\b,6\a,12\b,20Z)-3,12-dihydroxydammara-20(22),24-dien-6-yl 2-O-(6-deoxy-\a-L-mannopyranosyl)-

Open full local profile

1 matched or reported name

GINSENOSIDE RG4

Regulatory evidence across markets

None of the 13 markets tracked here holds an imported rule under the name GINSENOSIDE RG4.

That is a statement about this inventory, not about the law: no imported rule is not evidence that a substance is permitted. A rule may exist under a different name, under a CAS or EC number this glossary entry does not carry, or in a dataset not yet imported.

Check the markets and their sources Search every market for this name

Chemical identity and properties

PubChem 2D chemical structure for CAS 126223-28-7

CAS 126223-28-7PubChem CID 102004835

ginsenoside Rg4

(20E)-Ginsenoside F4 is a triterpenoid saponin. — ChEBI

IUPAC name: (2S,3R,4R,5R,6S)-2-[(2R,3R,4S,5S,6R)-2-[[(3S,5R,6S,8R,9R,10R,12R,13R,14R,17S)-3,12-dihydroxy-4,4,8,10,14-pentamethyl-17-[(2Z)-6-methylhepta-2,5-dien-2-yl]-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-6-yl]oxy]-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]oxy-6-methyloxane-3,4,5-triol

Molecular formula: C42H70O12
Molecular weight: 767.0 g/mol
Exact mass: 766.48672766 Da
XLogP3: 4.5
Topological polar surface area: 199.0 Å²
Hydrogen-bond donors: 8
Hydrogen-bond acceptors: 12
Covalent units: 1
Defined stereocentres: 20

Also known as

3,6,12-Trihydroxydammar-10(22),24-diene-O-rhamnosyl-(1-2)-glucopyranosideRefChem:143225(20E)-Ginsenoside F420(Z)-Ginsenoside F420(22)Z-ginsenoside F4CHEBI:176310HY-N6580TN1686

5 more reported names

EBC-616382FS-7062DA-53558DA-63766CS-0034276

Open full PubChem record PubChem annotations 3D structure image

External database identifiers

ChEBI:CHEBI:176310
EPA DTXSID:DTXSID801354850

Evidence from additional scientific databases

NIH PubChem PUG-View

Exact identifier match102004835

Attributed physical-property, hazard, environmental and use annotations.

Mapped by: Existing checksum-valid CAS to unique PubChem CID match. Retrieved: 2026-08-31. Open source record

Scientific classifications and hazard annotations provide context and do not replace the market-specific regulatory decision shown above.

Additional source coverage and match status

Source	Result	Checked
NIH PubChem PUG-View	Exact match	2026-08-31

A recorded no-match is useful evidence that the source was checked; it is not a claim that the substance does not exist elsewhere.

Retrieved from NIH PubChem on 2026-08-31 by checksum-valid CAS matching. Chemical properties do not replace the regulatory decision on this page.

Additional authoritative substance research

Each link searches that source for this identity. A link is a research route, not a claim that the source holds an exact record. What each source is, and its legal weight

Cosmetic Ingredient Review safety assessments FDA Global Substance Registration System ILO/WHO International Chemical Safety Cards Japan NITE-CHRIP NIOSH Pocket Guide to Chemical Hazards OECD eChemPortal US EPA CompTox CTX APIs

Take this record further

Screen in a formula Open standalone comparison

Official source and scope

Imported from Commission Implementing Decision (EU) 2025/1175 (dataset version EU 2025/1175). The glossary supplies common ingredient names for the ingredient list required by Article 19(1)(g); it is not an approval or safety list.

Open official Decision